Osteoporosis is a global public health problem, with fractures contributing to significant
morbidity and mortality. Although postmenopausal osteoporosis is most common, up to 30 …

Androgen deprivation therapy (ADT) has been the main management strategy for prostate
cancer for more than eight decades, nowadays achieved commonly by administration of …

Study Objective To examine the risks and compare the occurrences of major long‐term side
effects (sexual dysfunction, bone fractures, diabetes, cardiovascular morbidity, acute …

Exercise oncology is rapidly evolving, with impressive possibilities that may directly improve
patient outcomes in advanced prostate cancer. Research must focus on translating …

Background Hyperinsulinemia, obesity and related metabolic diseases are associated with
prostate cancer development. Prostate cancer patients undergoing androgen deprivation …

It has been a long-standing debate in the research and medical societies whether alcohol
consumption is linked to the risk of prostate cancer (PCa). Many comprehensive studies from …

Background: Androgen deprivation therapy (ADT) in prostate cancer has been shown to
deteriorate body composition (reduced lean mass and increased body and fat mass) and …

Background Androgen deprivation therapy (ADT) in patients with prostate cancer can have
several debilitating side effects. Supervised exercise is recommended to ameliorate these …

Background Osteoporosis is a skeletal disorder characterized by compromised bone
strength, resulting in increased fracture risk. Patients with prostate cancer may have multiple …

Computed tomography (CT) scans used in treatment response assessment in prostate
cancer (PCa) patients are a useful tool for nutritional status evaluation. The aim of this study …